Matthieu Gassiot

A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐<scp>TSLP</scp>/anti‐<scp>IL</scp>‐13 <scp>NANOBODY</scp>® compound, in healthy volunteers

Annemie Deiteren, Lieselot Bontinck, Griet Conickx et al. · Clinical and Translational Science · 2024 · 31 citations · Full text

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

Enrique M. Ocio, Aurore Perrot, Pierre Bories et al. · Leukemia · 2023 · 24 citations · Full text

Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients

Litaty Mbatchi, Jacques Robert, Marc Ychou et al. · Clinical Pharmacokinetics · 2016 · 23 citations

Health Sciences, Single Nucleotide Polymorphisms, Medicine +10

The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor

Nicolas Creusot, Matthieu Gassiot, Elina Alaterre et al. · Cells · 2020 · 21 citations · Full text

Oncogenic Agent, Hpxr Responsive Genes, Medicine +15

PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1

Alice Matheux, Matthieu Gassiot, Gaëlle Fromont et al. · Cancers · 2021 · 19 citations · Full text

Molecular Pharmacology, Perineural Invasion, Medicine +15